业务
货币单位:EUR
2025/FY
名称营收比例
Discovery & Preclinical Development (D&PD)5.29亿67.14%
Just – Evotec Biologics2.6亿32.93%
分部间抵销-49.6万-0.06%
地区
货币单位:EUR
2025/FY
名称营收比例
USA4.32亿54.73%
瑞士1.62亿20.50%
Rest Of The World7,708.5万9.78%
United Kingdom (UK)6,172.4万7.83%
德国2,529.3万3.21%
法国1,985.5万2.52%
Revenue from contributions1,129.4万1.43%
查看全部